about
Targeting the trimolecular complexType 1 diabetesEarly prediction of autoimmune (type 1) diabetes.An analysis of the cross-reactivity of autoantibodies to GAD65 and GAD67 in diabetes.Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy.Extrapancreatic autoantibody profiles in type I diabetesLessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.Rituximab selectively suppresses specific islet antibodies.Assessment of CD4+ T cell responses to glutamic acid decarboxylase 65 using DQ8 tetramers reveals a pathogenic role of GAD65 121-140 and GAD65 250-266 in T1D development.Antibodies against insulin measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes status.Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodiesInnate inflammation in type 1 diabetesThe pathogenesis and natural history of type 1 diabetes.ELISA Test for Analyzing of Incidence of Type 1 Diabetes Autoantibodies (GAD and IA2) in Children and AdolescentsMechanistic basis of immunotherapies for type 1 diabetes mellitusB Cell in Autoimmune Diseases.Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 DiabetesThe Frequency of Langerhans Islets β-Cells Autoantibodies (Anti-GAD) in Georgian Children and Adolescents with Chronic Autoimmune ThyroiditisPrevalence of Autoantibodies and HLA DR, DQ in Type 1 Diabetes MellitusAn important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of age.Islet autoantibody testing: an end to the trials and tribulations?Development of the Nonobese Diabetic Mouse and Contribution of Animal Models for Understanding Type 1 Diabetes.Prediction and prevention of Type 1 diabetes mellitus.Paraneoplastic encephalomyelopathies: pathology and mechanisms.Autoantibodies in the grocery shop: does quantity matter?The beta-cell in type 1 diabetes: What have we learned from proteomic studies?Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.Transcriptomic Segregation of Human Autoantigens Useful for the Diagnosis of Autoimmune Diseases.CD4+ T cells recognize diverse epitopes within GAD65: implications for repertoire development and diabetes monitoring.A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.The Role of Laboratory Testing in Differentiating Type 1 Diabetes from Type 2 Diabetes in Patients Undergoing Bariatric Surgery.Reversible adrenal insufficiency and heterophile antibodies in a case of autoimmune polyendocrinopathy syndrome.Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients.Latent autoimmune diabetes of adults: From oral hypoglycemic agents to early insulinOccurrence of type 1 diabetes in graves' disease patients who are positive for antiglutamic Acid decarboxylase antibodies: an 8-year followup study.A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults.Altered BCR signalling quality predisposes to autoimmune disease and a pre-diabetic state.The development of next-generation screening and diagnostic platforms will change diabetes care.
P2860
Q26864985-FAF1BAF8-2D3E-417B-AFA0-08BB31059337Q27000491-2FC0089A-3155-4AF5-AE44-3031499DE1E4Q33854613-BE62770C-37CD-4FF9-BEC8-19B6FA611145Q33873549-199EEDF0-B443-4976-9560-5FC9029A0637Q33950168-9AD91E1B-11BF-44C3-8058-FE82EF005F6EQ34428374-5DD4CD53-8973-46AA-B230-D8909B5C8F8CQ34604619-C8D2F34C-A2DD-40A0-864B-7ADA74F825AAQ34630695-D1C46D66-6484-41D5-85E8-2F437B32C4B0Q35123421-9F8245C8-6170-4B43-9ACA-2BF47B053621Q35227218-7B998295-BE2E-4EAE-BF68-95A8898C32D0Q35431818-CFE431E8-10CA-4183-B409-D5FC666E3C59Q35769051-CFEE39D3-EB91-417F-B49D-7318184B8CBCQ35976503-567E8F90-DE47-4167-9FFE-DE4EAFD2B953Q36225939-E7555BEA-D5EB-4B41-B04C-77E4E9863E48Q36526611-1006069B-EA1A-4E41-98CF-E4E1955C6500Q36681606-39E44197-C194-4376-A467-BBD26F54E93CQ36698793-911B6205-6DD5-40FF-A3C9-D95D8727BA8CQ36954468-06503168-81E6-468E-9CC5-E6D5C50B6772Q37036350-19B1AC94-343E-468B-8E3D-CDC6FE537F28Q37081053-65E9FA22-F548-4777-87D6-1C90AFE002F3Q37250784-0476254D-3343-4431-A071-65F301B85E04Q37261014-BCB1EAE1-08EB-4FC1-B41D-E84EB025FB69Q37333511-F67B7F83-C6B2-4ABB-837D-D4C2C1AAF322Q37713259-F3D32BBB-E992-4F34-846B-64BAFEF17CFDQ37809121-628DC7BD-9E7D-4B17-BF40-16BE3A0DC261Q37936924-ABB95490-7DB8-4BA4-BCC6-71EA25001FE9Q38097752-6825678C-E8E7-4841-8617-4C051D22A1F8Q38340362-E0B4620E-E57C-491A-A99A-6A29BC8B2BEFQ38734604-F9A73102-F459-4E3E-B2AF-7D6B5C8D8AC7Q38853161-B0516E83-1165-4A49-A263-C49AF27524F5Q39228782-0FFDC16E-5024-4250-9FDC-BA4B17C22E86Q39613776-C6B8B657-FF42-412C-95A4-427B10A26266Q40127909-A62E96E7-0991-40DA-893B-48EFDA1C16A0Q40346077-097152D4-94C2-4958-88F3-B89093304737Q41513696-74950F8E-6E7C-4285-96E3-179C3CF6843AQ41909159-E5E67959-8E92-46F3-9A36-08D4F49AD262Q42001671-B0D37F01-3B37-4470-87AD-28987D25FEF7Q42250838-5274AA3F-E139-47CC-AD4E-2BAFC9B89C33Q42260307-43F47812-75A4-4773-9CFA-E56185EDE7F0Q42278799-6A119F33-685B-4AF0-9080-B7AEE8C34096
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical applications of diabetes antibody testing.
@en
Clinical applications of diabetes antibody testing.
@nl
type
label
Clinical applications of diabetes antibody testing.
@en
Clinical applications of diabetes antibody testing.
@nl
prefLabel
Clinical applications of diabetes antibody testing.
@en
Clinical applications of diabetes antibody testing.
@nl
P356
P1476
Clinical applications of diabetes antibody testing.
@en
P2093
Polly J Bingley
P356
10.1210/JC.2009-1365
P407
P577
2009-10-29T00:00:00Z